• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Company Market
Company News
Company Stocks
  • Company Market
  • Company News
  • Company Stocks

Cameco Reports Third Quarter Financial and Operational Results

Kristen Moran
Nov. 02, 2015 09:36AM PST
Company News

Cameco (TSX:CCO,NYSE:CCJ) announced its consolidated financial and operational results for the third quarter, which showed a revenue of $649 million.

Cameco (TSX:CCO,NYSE:CCJ) announced its consolidated financial and operational results for the third quarter, which showed a revenue of $649 million.
As quoted in the press release:

Net losses attributable to equity holders this quarter were $4 million ($0.01 per share diluted) compared to net losses of $146 million ($0.37 per share diluted) in the third quarter of 2014. In addition to the items noted below, our net losses were affected by mark-to-market losses on foreign exchange derivatives. Net losses in the third quarter of 2014 included the impairment of our investment in GE-Hitachi Global Laser Enrichment of $184 million and the impairment of our investment in GoviEx Uranium Inc. of $12 million.
On an adjusted basis, our earnings this quarter were $78 million ($0.20 per share diluted) compared to earnings of $93 million ($0.23 per share diluted) (non-IFRS measure, see section) in the third quarter of 2014.
Net earnings in the first nine months of the year were $75 million ($0.19 per share diluted) compared to earnings of $113 million ($0.28 per share diluted) in the first nine months of 2014. In addition to the items noted below, our net earnings were affected by mark-to-market losses on foreign exchange derivatives. Our 2014 earnings also included a gain on the sale of our interest in BPLP of $127 million, the impairment of our investment in GE-Hitachi Global Laser Enrichment of $184 million and the impairment of our investment in GoviEx Uranium Inc. of $12 million.

Tim Gitzel, president and CEO of Cameco, commented:

Our results for the quarter and the first nine months are as expected with a higher proportion of our deliveries scheduled for the fourth quarter. We’ve continued to see the oversupply in the market impacting demand and price, and while we can’t control the pace of industry recovery, we can ensure that our company is ready at each step along the way. Our positive long-term view has not changed, so today that means preparing for the demand-driven market we see coming, by keeping our costs down and operating our mines safely and efficiently. Those mines continue to return excellent results, particularly Cigar Lake, which has already exceeded our 2015 production target range. The Cigar Lake operation, along with our other world-class assets, are at the core of our strategy to enhance our operating leverage and maintain the flexibility needed to respond quickly as the market improves.

Click here to read the full Cameco (TSX:CCO,NYSE:CCJ) press release.

tsx-cco nyse-ccj
The Conversation (0)

Go Deeper

AI Powered
Cameco

Cameco

Nuclear reactors with upward trending graph overlay.

Cameco, Kazatomprom Production Cuts Stoke Uranium Market Tightness

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES